Press releases Keep up with the latest news from Ikena Oncology. December 3, 2019 Kyn Therapeutics Rebrands as Ikena Oncology, Reflecting Next Phase of Growth May 7, 2019 Kyn Therapeutics Strengthens Leadership Team with Key Appointments February 4, 2019 Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer January 18, 2019 Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies December 19, 2018 Kyn Therapeutics Announces Initiation of Phase 1b/2 Clinical Studies of ARY-007 in Collaboration with Merck March 21, 2018 Kyn Therapeutics Appoints Chairman and Scientific Advisory Board Member December 14, 2017 Kyn Therapeutics Announces $49 Million Series A Capital Available to Develop Cancer Therapy Candidates with Novel Approaches to Major Immunometabolism Pathways Access our media kit page to view and download assorted corporate assets. View Media Kit
